A novel molecular mechanism modulating osteoclast differentiation and function

被引:225
作者
Yasuda, H
Shima, N
Nakagawa, N
Yamaguchi, K
Kinosaki, M
Goto, M
Mochizuki, SI
Tsuda, E
Morinaga, T
Udagawa, N
Takahashi, N
Suda, T
Higashio, K
机构
[1] Snow Brand Milk Prod Co Ltd, Life Sci Res Inst, Ishibashi, Tochigi 32905, Japan
[2] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan
关键词
osteoclasts; osteoblasts stromal cells; ODF; OPG OCIF; RANK; differentiation and function;
D O I
10.1016/S8756-3282(99)00121-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoclasts, the multinucleated giant cells that resorb bone, develop from hematopoietic cells of the monocyte/macrophage lineage. Osteoblasts, as well as bone marrow stromal cells, support osteoclast development through a mechanism of cell-to-cell interaction with osteoclast progenitors. We recently purified and molecularly cloned osteoclastogenesis inhibitory factor (OCIF), which was identical to osteoprotegerin (OPG). OPG/OCIF, a secreted member of the tumor necrosis factor (TNF) receptor family, inhibited differentiation and activation of osteoclasts, A single class of high-affinity binding sites for OPG/OCIF appeared on a mouse bone marrow stromal cell line, ST2, in response to 1 alpha,25-dihydroxyvitamin D3 [1,25(OH)(2)D-3] and dexamethasone (Dex), When the binding sites were occupied by OPG/OCIF, ST2 cells failed to support the osteoclast formation from spleen cells, To identify an OPG/OCIF ligand, we screened a cDNA expression library of STZ cells treated with 1,25(OH)(2)D-3 and Dex using OPG/OCIF as a probe. The cloned molecule was found to be a member of the membrane-associated TNF ligand family, and it induced osteoclast formation from mouse and human osteoclast progenitors in the presence of macrophage colony-stimulating factor (M-CSF) in vitro. Expression of its gene in osteoblasts/stromal cells was upregulated by osteotropic factors, such as 1,25(OH)(2)D-3, prostaglandin E-2 (PGE(2)), parathyroid hormone (PTH), and interleukin (IL)-11, A polyclonal antibody against this protein, as well as OPG/OCIF, negated not only the osteoclastogenesis induced by the protein, but also bone resorption elicited by various osteotropic factors in a fetal mouse long bone culture system. These findings led us to conclude that the protein is osteoclast differentiation factor (ODF), a long sought-after ligand that mediates an essential signal to osteoclast progenitors for their differentiation into active osteoclasts. Recent analyses of ODF receptor demonstrated that RANK, a member of the TNF receptor family, is the signaling receptor for ODF in osteoclastogenesis, and that OPG/OCIF acts as a decoy receptor for ODF to compete against RANK. The discovery of ODF, OPG/OCIF, and RANK opens a new era in the investigation of the regulation of osteoclast differentiation and function. (C) 1999 by Elsevier Science Inc, All rights reserved.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 40 条
[1]   Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy [J].
Akatsu, T ;
Murakami, T ;
Ono, K ;
Nishikawa, M ;
Tsuda, E ;
Mochizuki, SI ;
Fujise, N ;
Higashio, K ;
Motoyoshi, K ;
Yamamoto, M ;
Nagata, N .
BONE, 1998, 23 (06) :495-498
[2]   Osteoclastogenesis inhibitory factor suppresses osteoclast survival by intetfering in the interaction of stromal cells with osteoclast [J].
Akatsu, T ;
Murakami, T ;
Nishikawa, M ;
Ono, K ;
Shinomiya, N ;
Tsuda, E ;
Mochizuki, S ;
Yamaguchi, K ;
Kinosaki, M ;
Higashio, K ;
Yamamoto, M ;
Motoyoshi, K ;
Nagata, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :229-234
[3]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[4]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[5]   GENERATION OF OSTEOCLAST-INDUCTIVE AND OSTEOCLASTOGENIC CELL-LINES FROM THE H-2K(B)TSA58 TRANSGENIC MOUSE [J].
CHAMBERS, TJ ;
OWENS, JM ;
HATTERSLEY, G ;
JAT, PS ;
NOBLE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5578-5582
[6]   TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].
Fuller, K ;
Wong, B ;
Fox, S ;
Choi, YW ;
Chambers, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001
[7]  
Jimi E, 1996, J BIOL CHEM, V271, P4605
[8]   MACROPHAGE-COLONY-STIMULATING FACTOR AND INTERLEUKIN-1A MAINTAIN THE SURVIVAL OF OSTEOCLAST-LIKE CELLS [J].
JIMI, E ;
SHUTO, T ;
KOGA, T .
ENDOCRINOLOGY, 1995, 136 (02) :808-811
[9]  
JIMI E, 1998, 2 JOINT M ASBMR IBMS, pS222
[10]   TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption [J].
Kwon, BS ;
Wang, SA ;
Udagawa, N ;
Haridas, V ;
Lee, ZH ;
Kim, KK ;
Oh, KO ;
Greene, J ;
Li, YL ;
Su, J ;
Gentz, R ;
Aggarwal, BB ;
Ni, J .
FASEB JOURNAL, 1998, 12 (10) :845-854